Creo Medical Group PLC
LSE:CREO
Cash Flow Statement
Cash Flow Statement
Creo Medical Group PLC
Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||||
Net Income |
(8)
|
(15)
|
(14)
|
(16)
|
(17)
|
(20)
|
(21)
|
(25)
|
(28)
|
(27)
|
(25)
|
|
Depreciation & Amortization |
0
|
0
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
3
|
3
|
|
Other Non-Cash Items |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(4)
|
(2)
|
(2)
|
|
Cash Taxes Paid |
(2)
|
(2)
|
(0)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
|
Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
Change in Working Capital |
2
|
1
|
2
|
5
|
2
|
5
|
1
|
(1)
|
0
|
1
|
(1)
|
|
Cash from Operating Activities |
(7)
N/A
|
(14)
-104%
|
(13)
+7%
|
(12)
+11%
|
(16)
-35%
|
(16)
-2%
|
(19)
-16%
|
(26)
-38%
|
(29)
-12%
|
(25)
+14%
|
(24)
+2%
|
|
Investing Cash Flow | ||||||||||||
Capital Expenditures |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(6)
|
(8)
|
(3)
|
(2)
|
|
Other Items |
0
|
0
|
0
|
0
|
0
|
(20)
|
(20)
|
(2)
|
(2)
|
(3)
|
(19)
|
|
Cash from Investing Activities |
(1)
N/A
|
(1)
-55%
|
(0)
+62%
|
(1)
-66%
|
(1)
-36%
|
(21)
-1 813%
|
(21)
-1%
|
(8)
+63%
|
(9)
-18%
|
(6)
+36%
|
(21)
-254%
|
|
Financing Cash Flow | ||||||||||||
Net Issuance of Common Stock |
0
|
46
|
46
|
49
|
49
|
0
|
0
|
34
|
34
|
0
|
32
|
|
Net Issuance of Debt |
0
|
0
|
(0)
|
(0)
|
(0)
|
1
|
(0)
|
(2)
|
(1)
|
0
|
(1)
|
|
Cash from Financing Activities |
1
N/A
|
46
+9 167%
|
46
-1%
|
49
+7%
|
49
0%
|
1
-97%
|
0
-99%
|
32
+375 846%
|
34
+5%
|
1
-98%
|
31
+5 819%
|
|
Change in Cash | ||||||||||||
Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
Net Change in Cash |
(7)
N/A
|
31
N/A
|
32
+5%
|
36
+13%
|
32
-12%
|
(36)
N/A
|
(40)
-11%
|
(2)
+96%
|
(4)
-186%
|
(30)
-584%
|
(15)
+52%
|
|
Free Cash Flow | ||||||||||||
Free Cash Flow |
(8)
N/A
|
(16)
-100%
|
(14)
+11%
|
(13)
+7%
|
(17)
-34%
|
(17)
+3%
|
(19)
-16%
|
(32)
-65%
|
(37)
-14%
|
(28)
+23%
|
(26)
+7%
|